Implications of a bioresorbable vascular scaffold implantation on vessel wall strain of the treated and the adjacent segments

被引:0
|
作者
Christos V. Bourantas
Hector M. Garcia-Garcia
Carlos A. M. Campos
Yao-Jun Zhang
Takashi Muramatsu
Marie-Angèle Morel
Shimpei Nakatani
Xingyu Gao
Yun-Kyeong Cho
Yuki Isibashi
Frank J. H. Gijsen
Yoshinobu Onuma
Patrick W. Serruys
机构
[1] Erasmus Medical Center,Interventional Cardiology Department, Thoraxcenter
[2] Abbott Vascular,undefined
关键词
Bioresorbable vascular scaffold; Palpography; Vessel wall strain;
D O I
暂无
中图分类号
学科分类号
摘要
Background Metallic stents change permanently the mechanical properties of the vessel wall. However little is known about the implications of bioresorbable vascular scaffolds (BVS) on the vessel wall strain. Methods Patients (n = 53) implanted with an Absorb BVS that had palpographic evaluation at any time point [before device implantation, immediate after treatment, at short-term (6–12 months) or mid-term follow-up (24–36 months)] were included in the current analysis. The palpographic data were used to estimate the mean of the maximum strain values and the obtained measurements were classified using the Rotterdam classification (ROC) score and expressed as ROC/mm. Results Scaffold implantation led to a significant decrease of the vessel wall strain in the treated segment [0.35 (0.20, 0.38) vs. 0.19 (0.09, 0.29); P = 0.005] but it did not affect the proximal and distal edge. In patients who had serial palpographic examination the vessel wall strain continued to decrease in the scaffolded segment at short-term [0.20 (0.12, 0.29) vs. 0.14 (0.08, 0.20); P = 0.048] and mid-term follow-up [0.20 (0.12, 0.29) vs. 0.15 (0.10, 0.19), P = 0.024]. No changes were noted with time in the mechanical properties of the vessel wall at the proximal and distal edge. Conclusions Absorb BVS implantation results in a permanent alteration of the mechanical properties of the vessel wall in the treated segment. Long term follow-up data are needed in order to examine the clinical implications of these findings.
引用
收藏
页码:477 / 484
页数:7
相关论文
共 50 条
  • [41] Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial
    Chang, Chun-Chin
    Onuma, Yoshinobu
    Chevalier, Bernard
    West, Nick
    Gori, Tommaso
    Barbato, Emanuele
    Tarantini, Giuseppe
    Kocka, Viktor
    Achenbach, Stephan
    Dudek, Dariusz
    Escaned, Javier
    Abdel-Wahab, Mohamed
    Esposito, Giovanni
    Tijssen, Jan
    Morice, Marie-Claude
    Smits, Pieter
    Van Geuns, Robert-Jan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B165 - B165
  • [42] Medium Term Target Lesion Failure in Patient Treated with Bioresorbable Vascular Scaffold
    Liang, Michael Mao-Chen
    Kajiya, Takashi
    Lee, Ronald Chi-Hang
    Chan, Mark
    Tay, Edgar Lik-Wui
    Chan, Koo Hui
    Loh, Joshua P.
    Loh, Poay-Huan
    Tan, Huay Cheem
    Low, Adrian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (16) : S23 - S23
  • [43] Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance
    Costantini, Costantino R.
    Denk, Marcos A.
    De Macedo, Rafael M.
    Tarbine, Sergio G.
    Santos, Marcelo F.
    Luize, Marcio M.
    Folador, Joao C.
    Costantini, Costantino O.
    Stone, Gregg W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (01) : 48 - 55
  • [44] Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks
    Giacchi, Giuseppe
    Ortega-Paz, Luis
    Brugaletta, Salvatore
    Ishida, Kohki
    Sabate, Manel
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2015, 11 (03): : 161 - 169
  • [45] Procedure related platelet activation in long lesions treated with bioresorbable vascular scaffold versus xience xpedition implantation (proactive trial)
    Pellicano, M.
    Di Gioia, G.
    Toth, G.
    Ferrara, A.
    Adjedj, J.
    Delrue, L.
    Bartunek, J.
    Wijns, W.
    De Bruyne, B.
    Barbato, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 486 - 486
  • [46] Use of Intracoronary Imaging for Optimization of Bioresorbable Vascular Scaffold Implantation and Left Main Disease
    Tam, Weng Chio
    Lam, U. Po
    Ho, Wa
    Evora, De Brito Lima
    Alberto, Mario
    ACTA CARDIOLOGICA SINICA, 2019, 35 (04) : 437 - 438
  • [47] Optical Coherence Tomography for Coronary Bioresorbable Vascular Scaffold Implantation A Randomized Controlled Trial
    Lee, Seung-Yul
    Kang, Do-Yoon
    Hong, Sung-Jin
    Ahn, Jung-Min
    Ahn, Chul-Min
    Park, Duk-Woo
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Park, Seung-Jung
    Hong, Myeong-Ki
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (01)
  • [48] Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Garcia-Garcia, Hector M.
    Muramatsu, Takashi
    van Gems, Robert-Jan
    de Bruyne, Bernard
    Dudek, Dariusz
    Thuesen, Leif
    Smits, Pieter C.
    Chevalier, Bernard
    McClean, Dougal
    Koolen, Jacques
    Windecker, Stephan
    Whitbourn, Robert
    Meredith, Ian
    Dorange, Cecile
    Veldhof, Susan
    Hebert, Karine Miguel
    Rapoza, Richard
    Ormiston, John A.
    EUROINTERVENTION, 2014, 9 (11) : 1271 - 1284
  • [49] Subacute thrombosis after primary percutaneous coronary intervention with bioresorbable vascular scaffold implantation
    Tomaniak, Mariusz
    Kochman, Janusz
    Koltowski, Lukasz
    Pietrasik, Arkadiusz
    Rdzanek, Adam
    KARDIOLOGIA POLSKA, 2015, 73 (04) : 300 - 300
  • [50] Bioresorbable vascular scaffold implantation and scaffold edge dissection, to treat or not to treat? The dilemma clarified by optical coherence tomography
    Piraino, Davide
    Buccheri, Dario
    Andolina, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 214 : 399 - 400